arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Mirum Pharmaceuticals, Inc.

MIRM Health Care Biotechnology: Pharmaceutical Preparations
$100.90
Today
as of Sep 4, 16:51 ET
Last 30 days -10.10% Jul 28 → Sep 04
$92.64 $97.99 $103.35 $108.71 $114.07 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$99.08
High
$101.99
Low
$99.08
Volume
$343,864
Avg Vol
$798,003
Mkt Cap
$6.4B
P/E (TTM)
—
Beta
—
52w High
$130.00
52w Low
$63.23
Div Yield
—
Shares Out
$65M

Recent Press Releases & News last 60 days · 21 items

Sep 4 · 15:30 Zacks
Why Is Mirum Pharmaceuticals (MIRM) Up 6.9% Since Last Earnings Report?
Sep 2 · 20:01 PR Business Wire
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 20 · 07:54 MT Newswires
Mirum Pharmaceuticals Insider Sold Shares Worth $4,000,000, According to a Recent SEC Filing
▸ Show all 21 press releases & news Free account →

Overview

52-week range
$63
$130
56% of range
Avg surprise (last 3)
+29.0%
Avg reaction (last 2)
+2.3%
100% positive
Latest IV / EM
38%
EM ±5.9% · $100 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.94$-1.44$-0.94$-0.45$0.05 Actual $-0.80Actual $-1.94Actual $-0.57Actual $-0.54Actual $-0.52Actual $-0.30Actual $-0.30Est $-0.39Actual $-0.12Est $-0.31Actual $0.05Actual $-0.39Est $-0.40Actual $-1.06 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-790M$-546M$-303M$-59M$185M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.06 — — — — financials
Wed May 6, 2026Mar/2026 $-0.39 $-0.40 +2.5% -30.0% +4.0% earnings
Tue Sep 30, 2025Sep 2025 $0.05 — — — — financials
Wed Aug 6, 2025Jun/2025 $-0.12 $-0.31 +61.3% — — earnings
Wed May 7, 2025Mar/2025 $-0.30 $-0.39 +23.1% — +0.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.30 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.52 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.54 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.57 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.94 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.80 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$176M$160M—$133M$128M$112M—$90M
Cost of revenue————————
Gross profit————————
Operating income$-43M$-789M—$3M$-5M$-15M—$-13M
Net income$-67M$-790M—$3M$-6M$-15M—$-14M
EPS (diluted)$-1.06$-13.43—$0.05$-0.12$-0.30—$-0.30

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$331M$325M$297M$282M$228M$212M$223M$223M
Inventory$26M$26M$25M$24M$23M$22M$22M$22M
Total current assets$636M$569M$550M$531M$453M$411M$393M$387M
Total assets$1.04B$891M$843M$785M$726M$690M$671M$668M
Long-term debt————————
Total liabilities$1.06B$648M$528M$493M$471M$457M$445M$436M
Total equity$-10M$242M$315M$292M$255M$233M$226M$232M

Implied volatility — last 90 days

29%60%91%123%154% Jun 07 — IV 56% · EM ±7.8%Jun 08 — IV 53% · EM ±7.0%Jun 09 — IV 52% · EM ±6.6%Jun 10 — IV 56% · EM ±6.6%Jun 11 — IV 48% · EM ±5.3%Jun 12 — IV 29% · EM ±3.0%Jun 15 — IV 87% · EM ±6.3%Jun 16 — IV 88% · EM ±5.2%Jun 17 — IV 122% · EM ±5.1%Jun 19 — IV 42% · EM ±9.3%Jun 22 — IV 44% · EM ±9.1%Jun 23 — IV 43% · EM ±8.8%Jun 24 — IV 42% · EM ±8.4%Jun 25 — IV 42% · EM ±8.3%Jun 26 — IV 38% · EM ±7.2%Jun 29 — IV 41% · EM ±7.2%Jun 30 — IV 39% · EM ±6.8%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 38% · EM ±6.2%Jul 03 — IV 39% · EM ±6.2%Jul 06 — IV 38% · EM ±5.2%Jul 07 — IV 42% · EM ±5.6%Jul 08 — IV 52% · EM ±6.5%Jul 09 — IV 45% · EM ±5.3%Jul 10 — IV 55% · EM ±6.1%Jul 13 — IV 55% · EM ±4.6%Jul 14 — IV 61% · EM ±4.4%Jul 15 — IV 76% · EM ±4.5%Jul 16 — IV 112% · EM ±4.7%Jul 20 — IV 50% · EM ±11.9%Jul 21 — IV 51% · EM ±11.7%Jul 22 — IV 49% · EM ±11.3%Jul 23 — IV 50% · EM ±11.2%Jul 24 — IV 50% · EM ±11.1%Jul 27 — IV 54% · EM ±11.3%Jul 28 — IV 56% · EM ±11.4%Jul 29 — IV 49% · EM ±9.8%Jul 30 — IV 52% · EM ±10.3%Jul 31 — IV 56% · EM ±10.6%Aug 03 — IV 62% · EM ±10.9%Aug 04 — IV 63% · EM ±10.8%Aug 05 — IV 155% · EM ±25.9%Aug 06 — IV 42% · EM ±6.7%Aug 07 — IV 38% · EM ±6.0%Aug 10 — IV 52% · EM ±7.2%Aug 11 — IV 44% · EM ±5.9%Aug 12 — IV 40% · EM ±5.1%Aug 17 — IV 61% · EM ±5.1%Aug 18 — IV 51% · EM ±3.7%Aug 19 — IV 84% · EM ±5.0%Aug 20 — IV 126% · EM ±5.3%Aug 24 — IV 37% · EM ±7.7%Aug 25 — IV 35% · EM ±7.1%Aug 26 — IV 38% · EM ±7.7%Aug 27 — IV 30% · EM ±5.9%Aug 28 — IV 52% · EM ±9.9%Aug 31 — IV 35% · EM ±6.2%Sep 01 — IV 36% · EM ±6.2%Sep 02 — IV 37% · EM ±6.3%Sep 03 — IV 35% · EM ±5.7%Sep 04 — IV 38% · EM ±5.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in